Neuroaspis

Home / Neuroaspis

A NOVEL & PIONEER INTERVENTION FOR MULTIPLE SCLEROSIS

NEUROASPIS® plp10 is probably the first patented combination and specially formulated dietary supplement in Europe used for medical purposes in order to support the treatment of MS patients in particular and other related neurodegenerative diseases.

NEUROASPIS ® plp10 is a nutraceutical (with natural biomolecules), administered orally, can be co-administered with all other available treatments, showed great effect in reducing the frequency of relapses (flares) of the disease but mainly on the progression of the disability of patients.

 

FOOD SUPPLEMENT BASED ON FATTY ACIDS OMEGA-3 AND OMEGA-6 WITH VITAMIN E

NEUROASPIS® plp10 is a clinically validated food supplement comprising a patented combination of the highest quality omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) derived from fish oil and plant sources and antioxidant vitamin E.

The formula of NEUROASPIS® plp10 contains omega-3 molecules: DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) and omega-6 molecules: LA (linoleic acid), GLA (gamma linolenic acid) as polyunsaturated fatty acids (PUFAs). Monounsaturated fatty acids (MUFAs) such as oleic acid are also present in the product.

Omega-3 fatty acids (DHA and EPA) present in NEUROASPIS® plp10 help maintain normal brain function1, normal vision1 and contribute to the normal function of the heart2.

In addition, poly- and mono-unsaturated fats replace saturated fats in the diet contributing to the maintenance of normal blood cholesterol levels3.

In addition to omega-3 and omega-6 fatty acids, NEUROASPIS®plp10 also contains vitamin E known for the contribution to the protection of cells from oxidative stress and damage.

1 With a daily intake of 250 mg of DHA

2 With a daily intake of 250 mg of EPA and DHA

EC 1924/2006 high polyunsaturated fat

Posology and method of administration

Dosage

20ml, once daily, using the enclosed dose-calibration cup. Take 30 minutes before dinner or as suggested by your physician. Do not exceed the recommended daily dose.

Food Supplements should not be used in replacement of a balanced diet.

Under 18 years: please consult your physician.

NEUROASPIS® plp10 is a product of more than 10 years of research and clinical development.

The study was accepted and published in one of the most prestigious and World-renown medical scientific literature, the British Medical Journal, open edition, after an independent assessment by world-class scientists with knowledge, long-term experience and international recognition in research and treatment of MS. The product is registered for the USA and a world patent and is available for purchasing worldwide.

NEUROASPIS® plp10 is registered for the USA and a Worldwide patent and is Trade Marked Globally.
WORLD PATENT (WO2012131493) – COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISORDERS

PURCHASE

As clinical studies require NEUROASPIS® plp10 to be used continuously for six months (12 bottles) to show maximum performance.

Manufacturer & commercial rights holder: Aniva International S.A.

For more information please visit www.neuroaspis.com

CONTACT

Don’t hesitate to call.

Subscribe! Stay in touch with what is new in Aniva Pharma Serbia.

We keep your data private and share your data only with third parties that make this service possible. Read our Privacy Policy.